Related Experiment Videos

Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor

K B Reddy1, D Yee, S G Hilsenbeck

  • 1Department of Medicine/Medicaal Oncology, University of Texas Health Science Center at San Antonio 78284-7884.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|December 1, 1994
PubMed

Insights

Estrogen stimulates breast cancer cell growth by increasing transforming growth factor alpha (TGF alpha). Blocking TGF alpha production inhibits this estrogen-driven proliferation in ER-positive cells.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Estrogen (E2) stimulates growth in ER-positive breast cancer cells.
  • Transforming growth factor alpha (TGF alpha) is secreted by breast cancer cells upon E2 stimulation.

Purpose of the Study:

  • To investigate if TGF alpha mediates E2-induced growth in ER-positive breast cancer cells.
  • To determine the role of autocrine TGF alpha in estrogen-responsive breast cancer.

Main Methods:

  • Transfection of T47D cells with antisense TGF alpha mRNA expression vector.
  • Induction of antisense mRNA with cadmium to reduce TGF alpha expression.
  • Assessment of TGF alpha mRNA, protein, DNA synthesis, and cell proliferation.

Main Results:

  • Cadmium reduced TGF alpha mRNA and protein in antisense clones (AS1).
  • E2 increased TGF alpha and proliferation in all cell types.
  • Cadmium blocked E2-induced TGF alpha increase and proliferation in AS1 cells.

Conclusions:

  • Autocrine TGF alpha production is a significant contributor to E2-induced growth in T47D cells.
  • Targeting TGF alpha may be a therapeutic strategy for ER-positive breast cancer.

Related Concept Videos